Literature DB >> 29886357

Inhibition of PDE3A sustains meiotic arrest and gap junction of bovine growing oocytes in in vitro growth culture.

Md Hasanur Alam1, Jibak Lee2, Takashi Miyano2.   

Abstract

Bovine growing oocytes with a diameter of 105-115 μm from early antral follicles (1.2-1.8 mm) are able to resume meiosis, but lack the competence to mature to metaphase II. To confer full maturation competence onto the oocytes, culture systems which can support their growth and prevent their meiotic resumption during culture are needed. In this study, we cultured growing oocytes for 5 days to examine the effects of different phosphodiesterase (PDE) inhibitors on meiotic arrest and acquisition of full maturation competence of growing oocytes, and their gap junctional communication with cumulus cells. Growing oocyte-cumulus complexes (OCCs) were cultured with 3-isobutyl-1-methylxanthine (IBMX; broad-spectrum PDE inhibitor), rolipram (PDE4D inhibitor), cilostamide and milrinone (PDE3A inhibitors). The mean diameters of oocytes increased similarly in all groups. IBMX, cilostamide and milrinone induced antrum formation by OCCs and maintained meiotic arrest of oocytes during culture, whereas rolipram neither promoted antrum formation nor maintained oocyte meiotic arrest. Gap junctional communication between oocytes and cumulus cells was maintained by IBMX and cilostamide, but not by rolipram as judged by the transfer of injected lucifer yellow dye from oocytes to cumulus cells. In subsequent in vitro maturation, oocytes grown with IBMX, cilostamide and milrinone showed full maturation competence. These results suggest that PDE3A inhibition maintains the meiotic arrest of bovine growing oocytes and sustains their gap junctional communication with cumulus cells for 5 days, thereby contributing to their acquisition of full maturation competence.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antrum formation; Bovine oocyte; Gap junction; Meiotic arrest; Phosphodiesterase

Mesh:

Substances:

Year:  2018        PMID: 29886357     DOI: 10.1016/j.theriogenology.2018.05.028

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  7 in total

1.  Recreating the Follicular Environment: A Customized Approach for In Vitro Culture of Bovine Oocytes Based on the Origin and Differentiation State.

Authors:  Alberto Maria Luciano; Rodrigo Garcia Barros; Ana Caroline Silva Soares; Jose Buratini; Valentina Lodde; Federica Franciosi
Journal:  Methods Mol Biol       Date:  2021

2.  High cGMP and low PDE3A activity are associated with oocyte meiotic incompetence.

Authors:  Eran Gershon; Iris Maimon; Dalia Galiani; Michal Elbaz; Sharon Karasenti; Nava Dekel
Journal:  Cell Cycle       Date:  2019-08-12       Impact factor: 4.534

3.  Effects of estradiol on in vitro maturation of buffalo and goat oocytes.

Authors:  Hurum Maksura; Narsisa Akon; Md Nuronnabi Islam; Ireen Akter; Avijit Kumar Modak; Asma Khatun; Md Hasanur Alam; Md Abul Hashem; Md Ruhul Amin; Mohammad Moniruzzaman
Journal:  Reprod Med Biol       Date:  2020-09-25

4.  In vitro growth of bovine oocytes in oocyte-cumulus cell complexes and the effect of follicle stimulating hormone on the growth of oocytes.

Authors:  Mihoko Fushii; Rie Yamada; Takashi Miyano
Journal:  J Reprod Dev       Date:  2020-10-30       Impact factor: 2.214

5.  L-Carnitine Supports the In Vitro Growth of Buffalo Oocytes.

Authors:  Avijit Kumar Modak; Md Hasanur Alam; Md Nuronnabi Islam; Nipa Paul; Ireen Akter; Md Abul Hashem; Akm Ahsan Kabir; Mohammad Moniruzzaman
Journal:  Animals (Basel)       Date:  2022-08-02       Impact factor: 3.231

6.  GDF9 and BMP15 induce development of antrum-like structures by bovine granulosa cells without oocytes.

Authors:  Md Hasanur Alam; Jibak Lee; Takashi Miyano
Journal:  J Reprod Dev       Date:  2018-07-21       Impact factor: 2.214

Review 7.  Interaction between growing oocytes and granulosa cells in vitro.

Authors:  Md Hasanur Alam; Takashi Miyano
Journal:  Reprod Med Biol       Date:  2019-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.